No profile data available.
Canopy Growth Corporation (CGC) is an essential consumer products company in the marijuana product manufacturing industry, based in Smiths Falls, Canada, with about 1,128 full-time employees.
It reported revenue of 284.60 million CAD for fiscal year 2026, up 5.8% from fiscal year 2025, and net income of -262.91 million CAD. In Q1 2027 (the quarter ended June 30, 2026) revenue was 81.17 million CAD, up 12.5% from a year before. Its largest business segment, Cannabis, brought in 75% of segment revenue in fiscal year 2026; Canada was the largest region with 65%. Its market capitalization was $371.62 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended March 31, 2026; market data as of October 9, 2026.
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and internationally. The company operates through two segments, Cannabis and Storz & Bickel.
Canopy Growth reported 284.60 million CAD in revenue for fiscal year 2026, up 5.8% from 269.00 million CAD in fiscal year 2025. In Q1 2027 revenue was 81.17 million CAD.
Cannabis, with 213.94 million CAD or 75% of segment revenue in fiscal year 2026. Next: Storz & Bickel (25%).
Canada: 65% of revenue by region in fiscal year 2026, followed by Germany (22%).
$371.62 million as of October 9, 2026.
Listed companies of a similar size in the same industry (marijuana product manufacturing) include Cronos Group Inc. (CRON), Vireo Growth Inc. (VREOF), Aurora Cannabis Inc. (ACB), Cresco Labs Inc. (CRLBF).